Non-Invasive Determination of Fetal Chromosome Abnormalities



Status:Completed
Conditions:Other Indications, Women's Studies
Therapuetic Areas:Other, Reproductive
Healthy:No
Age Range:18 - Any
Updated:4/2/2016
Start Date:January 2009
End Date:December 2009

Use our guide to learn which trials are right for you!

The overall significance of this study is to develop a laboratory developed test (LDT) to
use a new marker in the maternal blood to better identify pregnancies that have a child with
a chromosome abnormality such as Down syndrome (trisomy 21), Edward's syndrome (trisomy 18),
Patau syndrome (trisomy 13), Klinefelter syndrome, (47, XXY), and other chromosome
abnormalities. Accomplishing that task would reduce the need for invasive amniocentesis and
CVS procedures.


Inclusion Criteria:

- This study is only applicable to women who are between 8 and 30 weeks' gestation and
who have been determined increased risk for fetal aneuploidy. In the interest of
expediting and simplifying this study, the investigators want only women who have
already decided to undergo second-trimester amniocentesis or CVS.

Exclusion Criteria:

- The only exclusion criteria are those mentioned.
We found this trial at
7
sites
259 1st St
Mineola, New York 11501
(516) 663-0333
Winthrop University Hospital Founded in 1896 by a group of local physicians and concerned citizens,...
2451
mi
from 91732
Mineola, NY
Click here to add this to my saved trials
UVM
Burlington, Vermont 05405
2467
mi
from 91732
Burlington, VT
Click here to add this to my saved trials
Moristown, New Jersey 07960
2406
mi
from 91732
Moristown, NJ
Click here to add this to my saved trials
New Hyde Park, New York 11042
2448
mi
from 91732
New Hyde Park, NY
Click here to add this to my saved trials
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
New York, New York 10128
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
Rockville, Maryland 20850
2272
mi
from 91732
Rockville, MD
Click here to add this to my saved trials